Spengler, Mark (Chimera Biotec 201402– Managing Director) |
Managing Director |
Kompass (Group) |
Germany |
Spengler, Peter |
n. a. |
Volks- und Raiffeisenbanken (DE) (Group) |
Germany |
Spengler, Ulrich (Astra Diagnostics 201105 Managing Director before Artus Managing Director) |
Managing Director |
ADT Altona Diagnostic Technologies GmbH (Altona Diagnostics) |
Germany |
Sperl, Stefan (Panoptes Pharma GmbH 201309 COO + Co-founder) |
Chief Operating Officer (COO) |
Panoptes Pharma GmbH |
Austria |
Spertini, Francois (Anergis 2007 President Board of Directors) |
President/Director/Head Business Group/Unit/Division |
Anergis S.A. |
Switzerland |
Spetea, Mariana (AlcaSynn 200606 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sanochemia (Group) |
Austria |
Spiecker, Heinrich (LaVision BioTec GmbH 201810 Managing Director) |
Managing Director |
Miltenyi Biotec (Group) |
Germany |
Spiekerkötter, Jörg (Paion 201408 Chairman of Supervisory Board before Organon Bioscience 200611–200705 CFO) |
Supervisory Board Member |
Humanwell Healthcare (Group) |
Germany |
Spiekermann, Meike (miRdetect GmbH 2016– Managing Director + Company Founder) |
Managing Director |
miRdetect GmbH |
Germany |
Spillner, Enno (Formycon 202304– CFO before Evotec + 4SC + BioM Venture Capital GmbH) |
Chief Financial Officer (CFO) |
Formycon (Group) |
Germany |
Spinner, Thomas L. (Advent International GmbH 2003) |
n. a. |
Advent International (Group) |
Germany |
Spitadakis, Georgios (Roche 201307 Global Head of Workflow + IT at Roche Professional Diagnostics) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
Spiteller, Peter (Univ Bremen 201310) |
n. a. |
University of Bremen |
Germany |
Spitra, Jonas (Schott 201906 Manager Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Schott (Group) |
Germany |
Spitz, Charlotte (Trophic Communications 202108) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
Spitz, Urs (Biosynth 201905 CEO) |
Chief Executive Officer (CEO) |
Biosynth (since 9/22) (Group) |
Switzerland |
Spitzenpfeil, Thomas (Carl Zeiss 201312 CFO) |
Chief Financial Officer (CFO) |
Carl Zeiss (Group) |
Germany |
Spitznagel, Martin (Bind-X 202308 CEO) |
Chief Executive Officer (CEO) |
Bind-X (Group) |
Germany |
Splawski, Igor (CureVac –202307 CSO RESIGNED 7/23) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
CureVac (Group) |
Germany |
Spleiss, Johannes (Zeria 202307 Head Scientific Affairs Tillotts Pharma + 202307– CEO of Mage Biologics) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Zeria (Group) |
Switzerland |
Spoerry, Robert F. (Mettler Toledo –200711– Executive Chairman) |
n. a. |
Mettler-Toledo (Mettler Toledo) (Group) |
Switzerland |
Spohr, Anders Bendsen (Novo Group 202004 Senior Partner Prinicpal Investments at Novo Holdings) |
Partner (venture partner) |
Novo Group (Group) |
Denmark |
Spori, Bodo (Domainex 201803– Head BusDev Europe before Cyprotex + Scottish Biomedical Ltd) |
Business Development Manager / Strategy Manager |
Domainex Ltd. |
United Kingdom (GB) |
Spota, Donato (Basilea 201311– CFO joined 2002 before Roche) |
Chief Financial Officer (CFO) |
Basilea (Group) |
Switzerland |
Spraul, Manfred (Bruker 201307 Director Apllied NMR Business Development) |
Business Development Manager / Strategy Manager |
Bruker (Group) |
United States (USA) |
Spreitz, Peter (Trinos 1997– Managing Director + co-founder Trinos Vakuum-Systeme GmbH) |
Managing Director |
Pfeiffer Vacuum (Group) |
Germany |
Sprenger-Haussels, Markus (Qiagen 201703 Senior Director + Head Sample Technologies Life Sciences) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
Germany |
Spring, Mark (Genoptix 201703– CFO before Prometheus Laboratories) |
Chief Financial Officer (CFO) |
Genoptix Inc. |
United States (USA) |
Springer, Sebastian (Jacobs Univ Bremen 201103 Associate Professor Biochemistry and Cell Biology) |
Assistant Professor / Associate Professor |
Schaffhausen Institute of Technology (SIT) |
Germany |
Sproll, Marlies (MorphoSys 201711– Special Adviser to CEO before 200510–201710 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Novartis (Group) |
Germany |
Spura, Armin (Crown Bioscience 202006 CEO at Crown Bioscience Inc) |
Chief Executive Officer (CEO) |
JSR Corporation (Group) |
United States (USA) |
Spycher, Philipp (Araris Biotech 201902– CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Araris Biotech AG |
Switzerland |
Späth, Lothar |
n. a. |
Nationaler Ethikrat (DE) |
Germany |
Srega, Jürgen (Bruker 201302– President Bruker CALID Group before BRAHMS + Thermo Fisher Bremen) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
Srinivasan, Kumar (AstraZeneca 201602 VP SP&A before Probiodrug + Wyeth Pharma + Torrey Pines) |
Business Development Manager / Strategy Manager |
AstraZeneca (Group) |
|
Sruthi, Sudha (Kyan Technologies 202309 Corporate Development) |
Business Development Manager / Strategy Manager |
Kyan Technologies Pte Ltd. |
Singapore |
St-Onge, Luc (Apceth Biopharma 201708 before Ganymed + Affectis CBO + DeveloGen) |
Business Development Manager / Strategy Manager |
Minaris Regenerative Medicine (Group) |
Germany |
Staab, H. A. (Univ Heidelberg 1964 Prof Institute for Organic Chemistry) |
Professor |
University of Heidelberg (Ruperto Carola) |
Germany |
Staatz-Granzer, Irina (Staatz Business Development & Strategy 2006– + U3 Pharma 200804 CEO) |
consulting (economic) |
Staatz Business Development & Strategy – Dr. Irina Staatz-Granzer |
Germany |
Stadler, Elisabeth (Vienna Insurance Group 202005 CEO) |
Chief Executive Officer (CEO) |
Vienna Insurance Group (VIG) |
Austria |
Stadler, Herbert (Cell.Copedia 201506 CEO before Synaptic Systems + Affectis/Neuronova 2002–201003 CEO + DeveloGen CEO) |
Chief Executive Officer (CEO) |
Cell.Copedia GmbH (CellCopedia) |
Germany |
Stadler, Moritz Philipp (Heidelberg Delivery Technologies 201707– Managing Director) |
Managing Director |
Heidelberg Delivery Technologies GmbH |
Germany |
Stadler, Peter J. W. (Artemis 199712– Managing Director also VBU Board Member 200706) |
Managing Director |
Taconic (Group) |
Germany |
Stadler, Volker (Pepperprint GmbH 201102 Managing Director) |
Managing Director |
Pepperprint GmbH |
Germany |
Staehelin, Barbara (Dybly 201405 CEO before SIRS-Lab Managing Director before Global Exec Committee Roche Diagnostics) |
Chief Executive Officer (CEO) |
Dybly AG |
Switzerland |
Staehelin, Matthias (Vischer 200505) |
n. a. |
Vischer – Anwälte und Notare |
Switzerland |
Staffelbach, Thomas (Santhera 201108 Head Public + Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Santhera (Group) |
Switzerland |
Staffler, Günther (Affiris 201706 CTO) |
Chief Technology/Technical Officer (CTO) |
Affiris AG |
Austria |
Stafford, Jeffrey A. (Jecure Therapeutics 201811 CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
Stafforst, Thorsten (Univ Tübingen 202309 Professor + Co-Founder of AIRNA) |
Professor |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
Stage, Henrik (Adcendo 202107– CFO before CEO formerly Santaris Pharma 201401 CFO) |
Chief Financial Officer (CFO) |
Adcendo ApS |
Denmark |
Stahl, Eva (Mecuris 20191 Head of Marketing) |
Sales Manager / Marketing Manager |
Mecuris GmbH |
Germany |
Stahl, Hans J. (Aerodata 201303 CEO) |
Chief Executive Officer (CEO) |
Aerodata (Group) |
Germany |
Stahl, Stefan (Stahl-Electronics 201009) |
Company Founder |
Stahl-Electronics Dr. Stefan Stahl |
Germany |
Stahlberg, Dirk (ACURIS Rechtsanwälte 200902) |
Patent Attorney |
ABK Patent, Trademark and Design Attorneys (Berlin) |
Germany |
Stahlberg, Silke (Central BioHub GmbH 201801 Managing Director) |
Managing Director |
Central BioHub GmbH |
Germany |
Stahnke, Bettina (Insilico Biotechnology 201402 Business Development Manager) |
Business Development Manager / Strategy Manager |
Yokogawa (Group) |
Germany |
Stampe, Malte (Prolupin GmbH 202010 CEO) |
Chief Executive Officer (CEO) |
Prolupin GmbH |
Germany |
Staner, Dan (Moderna 202009– VP + Managing Director Moderna Switzerland before Eli Lilly) |
Managing Director |
Moderna (Group) |
Switzerland |
Stanesa, Ann (Ten Bridge Communications 201704) |
Public Relations Manager / Investor Relations Manager |
Ten Bridge Communications (US) |
United States (USA) |
Stange, Mirko (SilverSky LifeSciences 2019045 Managing Director before Ventac Partners + Miacom Diagnostics) |
Partner (venture partner) |
SilverSky (Group) (Silversky Lifesciences) |
Germany |
Stangenberg-Haverkamp, Frank (Merck (DE) 201401– Chairman of Family Board of E Merck) |
Supervisory Board |
Merck (DE) (Group) |
Germany |
Stangier, Kerstin (Azenta Life Sciences Leipzig 202205 Senior Director formerly GATC Biotech 201107 Director BusDev) |
Business Development Manager / Strategy Manager |
Azenta (Group) |
Germany |
Stanjek, Antje |
n. a. |
Nationales Genomforschungsnetz (NGFN) (DE) |
Germany |
Stapelfeldt, Dorothee (Hamburg (govt) 201104 Minister of Science, SPD) |
Minister |
Hamburg (govt region) |
Germany |
Stapp, Ralf (Bremen (govt) 201110– Managing Director of Bremer Aubau-Bank GmbH before Sparkasse Lüneburg) |
Managing Director |
Bremen (govt region) |
Germany |
Stark-Watzinger, Bettina (Germany (govt) 202406 Federal Minister of Education + Research) |
Minister |
Germany (govt) |
Germany |
Starke, Joachim (TO DO Life Sciences 200912 Managing Director) |
Managing Director |
TO DO Life Sciences (Group) |
Germany |
Starmans, Luc (Brightlands Venture Partners 202408 Partner) |
Partner (venture partner) |
Brightlands Venture Partners (BVP) |
Belgium |
Starnecker, Alexander (Rentschler 201710 Manager Company Development) |
Business Development Manager / Strategy Manager |
Rentschler (Group) |
Germany |
Stars, Hauke (Deutsche Börse 201611 Executive Board Member for Cash Market + Pre-IPO + Growth Financing) |
Board member, executive |
Deutsche Börse (Group) |
Germany |
Starynska, Anna (Cardiolyse Oy 202003 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cardiolyse Oy |
Finland |
Stas, Philippe (Trinean 201204– CEO before Lonza + AlgoNomics 200712–2009 CEO + PerkinElmer + KeyGene) |
Chief Executive Officer (CEO) |
Unchained Labs (Group) |
Belgium |
Statnik, Michael (Biolago 201011 President) |
n. a. |
BioLAGO e. V. |
Germany |
Staub, Uwe (Epimune 201904– Managing Director before Epigenomics + Qiagen + Digene + Abbott Diagnostics) |
Managing Director |
Epimune GmbH |
Germany |
Stauber, Jonathan (ImaBiotech 201206 CEO) |
Chief Executive Officer (CEO) |
ImaBiotech (Group) |
France |
Stauder, Gerhard (Antisense Pharma 200204 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Isarna Therapeutics GmbH |
Germany |
Staudigl, Rudolf (Wacker 201602 CEO) |
Chief Executive Officer (CEO) |
Wacker (Group) |
Germany |
Staudinger, Elisabeth (Siemens 202010 President Asia Pacific at Siemens Healthineers) |
President/Director/Head Business Group/Unit/Division |
Siemens (Group) |
Germany |
Staudt, Elmer |
n. a. |
Volks- und Raiffeisenbanken (DE) (Group) |
Germany |
Stauffer, Peter (Fielmann Group 202105 Managing Director of Fielmann Family Office) |
Managing Director |
FIELMANN Group (family Fielmann) |
Germany |
Stavros, Pete (Kohlberg Kravis Roberts 201612 Head of Industrial Investing Team) |
Investment Manager |
KKR (Kohlberg Kravis Roberts) (Group) |
United States (USA) |
Stec-Niemczyk, Justyna (Selvita 201503 Head of Protein Chemistry Lab) |
Laboratory Manager (industry) |
Selvita (Group) |
Poland |
Steck, Oliver |
n. a. |
Vector Capital |
Germany |
Steckbeck, Jonathan (Peptilogics 202012 CEO + Founder) |
Chief Executive Officer (CEO) |
Peptilogics Inc. |
United States (USA) |
Steckeler, Julia (MedicalMountains 202408 Managing Director) |
Managing Director |
MedicalMountains GmbH (formerly AG) |
Germany |
Steeb, Lothar (PeloBiotech GmbH 201202– Managing Director) |
Managing Director |
PeloBiotech GmbH |
Germany |
Steedman, Mark A. (Fibrocor Therapetuics 202001 CEO) |
Chief Executive Officer (CEO) |
Fibrocor Therapeutics Inc. |
Canada |
Steeger, Anna (Myelo Therapeutics 202311 Managing Director) |
Managing Director |
Pentixapharm (Group) |
Germany |
Steeger, Uta (Shimadzu 201204 Manager Advertising + PR + Exhibitions at Shimadzu Europea GmbH) |
Public Relations Manager / Investor Relations Manager |
Shimadzu (Group) |
Germany |
Steel, James (Peel Hunt 201707) |
n. a. |
Peel Hunt LLP |
United Kingdom (GB) |
Stefancic, Matej (EFOS (SI) 202209 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
EFOS (Trapview) (Group) |
Slovenia |
Steffen, Beat (Novartis 202010 at Novartis Venture Fund) |
Investment Manager |
Novartis (Group) |
Switzerland |
Steffen, Daniel (Berlin (govt) 201908 Senior Investment Manager at IBB Beteiligungsgesellschaft) |
Investment Manager |
Berlin (govt region) |
Germany |
Steffen, Günter (ZFHN Zukunfsfonds Heilbronn + 4/10 existent Chair Advisory Board of PANATecs) |
Investment Manager |
Zukunftsfonds Heilbronn (Group) |
Germany |
Steffen, Matthias (Fuse GmbH 201404 Managing Director + Founder) |
Managing Director |
Fuse GmbH Integrierte Kommunikation und Neue Medien |
Germany |
Stege, Matthias (Exelonix GmbH 201308 Managing Director + Co-founder) |
Managing Director |
Exelonix GmbH |
Germany |
Stegemann, Jens (Breath Therapeutics 201609– CEO) |
Managing Director |
Zambon (Group) |
Germany |
Steger, Monika (Bavaria (govt) 202409 Managing Director of Bayern Kapital before 201604 Investment Manager) |
Managing Director |
Bavaria (govt region) |
Germany |
Stegmeier, Frank (KSQ Therapeutics 2015– CSO before Novartis Head of Oncology Target Discovery) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
KSQ Therapeutics Inc. |
United States (USA) |